000 01440 a2200409 4500
005 20250517080000.0
264 0 _c20170103
008 201701s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep20488
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMöginger, Uwe
245 0 0 _aCross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites.
_h[electronic resource]
260 _bScientific reports
_cFeb 2016
300 _a20488 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBacterial Proteins
_xchemistry
650 0 4 _aBinding Sites
650 0 4 _aChromatography, Liquid
650 0 4 _aEpitopes
_xmetabolism
650 0 4 _aPolysaccharides
_xchemistry
650 0 4 _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
650 0 4 _aVaccines, Conjugate
_xchemistry
700 1 _aResemann, Anja
700 1 _aMartin, Christopher E
700 1 _aParameswarappa, Sharavathi
700 1 _aGovindan, Subramanian
700 1 _aWamhoff, Eike-Christian
700 1 _aBroecker, Felix
700 1 _aSuckau, Detlev
700 1 _aPereira, Claney Lebev
700 1 _aAnish, Chakkumkal
700 1 _aSeeberger, Peter H
700 1 _aKolarich, Daniel
773 0 _tScientific reports
_gvol. 6
_gp. 20488
856 4 0 _uhttps://doi.org/10.1038/srep20488
_zAvailable from publisher's website
999 _c25699136
_d25699136